Scientific Reports (Oct 2023)

CANVAS-related RFC1 mutations in patients with immune-mediated neuropathy

  • Makito Hirano,
  • Motoi Kuwahara,
  • Yuko Yamagishi,
  • Makoto Samukawa,
  • Kanako Fujii,
  • Shoko Yamashita,
  • Masahiro Ando,
  • Nobuyuki Oka,
  • Mamoru Nagano,
  • Taro Matsui,
  • Toshihide Takeuchi,
  • Kazumasa Saigoh,
  • Susumu Kusunoki,
  • Hiroshi Takashima,
  • Yoshitaka Nagai

DOI
https://doi.org/10.1038/s41598-023-45011-8
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) has recently been attributed to biallelic repeat expansions in RFC1. More recently, the disease entity has expanded to atypical phenotypes, including chronic neuropathy without cerebellar ataxia or vestibular areflexia. Very recently, RFC1 expansions were found in patients with Sjögren syndrome who had neuropathy that did not respond to immunotherapy. In this study RFC1 was examined in 240 patients with acute or chronic neuropathies, including 105 with Guillain-Barré syndrome or Miller Fisher syndrome, 76 with chronic inflammatory demyelinating polyneuropathy, and 59 with other types of chronic neuropathy. Biallelic RFC1 mutations were found in three patients with immune-mediated neuropathies, including Guillain-Barré syndrome, idiopathic sensory ataxic neuropathy, or anti-myelin-associated glycoprotein (MAG) neuropathy, who responded to immunotherapies. In addition, a patient with chronic sensory autonomic neuropathy had biallelic mutations, and subclinical changes in Schwann cells on nerve biopsy. In summary, we found CANVAS-related RFC1 mutations in patients with treatable immune-mediated neuropathy or demyelinating neuropathy.